InvestorsObserver
×
News Home

Is Wave Life Sciences Ltd (WVE) Stock at the Top of the Biotechnology Industry?

Wednesday, June 22, 2022 12:50 PM | InvestorsObserver Analysts

Mentioned in this article

Is Wave Life Sciences Ltd (WVE) Stock at the Top of the Biotechnology Industry?

Wave Life Sciences Ltd (WVE) is near the top in its industry group according to InvestorsObserver. WVE gets an overall rating of 77. That means it scores higher than 77 percent of stocks. Wave Life Sciences Ltd gets a 96 rank in the Biotechnology industry. Biotechnology is number 38 out of 148 industries.

Overall Score - 77
WVE has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on WVE!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Wave Life Sciences Ltd Stock Today?

Wave Life Sciences Ltd (WVE) stock is trading at $2.44 as of 12:38 PM on Wednesday, Jun 22, an increase of $0.38, or 18.45% from the previous closing price of $2.06. The stock has traded between $2.16 and $2.79 so far today. Volume today is more active than usual. So far 1,011,840 shares have traded compared to average volume of 385,478 shares. Click Here to get the full Stock Report for Wave Life Sciences Ltd stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App